Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: A dual-laboratory study

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 947-956

  Maple, Peter A C ^a   Hedman, Lea ^b,c   Dhanilall, Pravesh ^a   Kantola, Kalle ^b   Nurmi, Visa ^b   Söderlund Venermo, Maria ^b   Brown, Kevin E ^b   Hedman, Klaus ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN VP1; PROTEIN VP2;

ADULT; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CHILD; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DILUTION; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROLOGY; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; FEMALE; FINLAND; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONDON; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD; YOUNG ADULT;

EID: 84896697709     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02613-13     Document Type: Article

References (32)

1. Brown KE. 2010. The expanding range of parvoviruses which infect humans. Rev. Med. Virol. 20:231-244. http://dx.doi.org/10.1002/rmv.648.
2. Slavov SN, Kashima S, Pinto ACS, Covas DT. 2011. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol. Med. Microbiol. 62:247-262. http://dx.doi.org/10.1111/j.1574-695X.2011.00819.x.
3. Servant-Delmas A, Lefrere J-J, Morinet F, Pillet S. 2010. Advances in human B19 erythrovirus biology. J. Virol. 84:9658-9665. http://dx.doi.org/10. 1128/JVI.00684-10.
4. Lu J, Zhi N, Wong S, Brown KE. 2006. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J. Infect. Dis. 193:582-590. http://dx.doi.org/10.1086/499599. (Pubitemid 43202750)
5. Filippone C, Zhi N, Wong S, Lu J, Kajigaya S, Gallinella G, Kakkola L, Söderlund-Venermo M, Young NS, Brown KE. 2008. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology 374:444-452. http://dx.doi.org/10.1016/j.virol.2008.01.002.
6. Mortimer PP. 1984. The 80th year of fifth disease. BMJ 289:338-339. http://dx.doi.org/10.1136/bmj.289.6441.338. (Pubitemid 14019735)
7. de Jong EP, de Haan TR, Kroes ACM, Beersma MFC, Oepkes D, Walther FJ. 2006. Parvovirus B19 infection in pregnancy. J. Clin. Virol. 36:1-7. http://dx.doi.org/10.1016/j.jcv.2006.01.004. (Pubitemid 44360575)
8. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS. 1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426-429. http://dx.doi.org/10.1038/302426a0. (Pubitemid 13164328)
9. Heegaard ED, Brown KE. 2002. Human parvovirus B19. Clin. Microbiol. Rev. 15:485-505. http://dx.doi.org/10.1128/CMR.15.3.485-505.2002. (Pubitemid 34761354)
10. Yates AM, Hankins JS, Mortier NA, Aygun B, Ware RE. 2009. Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease. Pediatr. Blood Cancer 53:479-481. http://dx.doi.org/10. 1002/pbc.22035.
11. Mogensen TH, Jensen JMB, Hamilton-Dutoit S, Larsen CS. 2010. Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect. Dis. 10:246. http://dx.doi.org/10.1186/1471-2334-10-246.
12. Cohen BJ, Mortimer PP, Pereira MS. 1983. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J. Hyg. Camb. 91:113-130. http://dx.doi.org/10.1017/S00221724 00060095. (Pubitemid 14229522)
13. Peterlana D, Puccetti A, Corrocher R, Lunardi C. 2006. Serologic and molecular detection of parvovirus B19 infection. Clin. Chim. Acta 372: 14-23. http://dx.doi.org/10.1016/j.cca.2006.04.018. (Pubitemid 44376375)
14. Söderlund M, Brown CS, Spaan WJ, Hedman L, Hedman K. 1995. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis. 172:1431-1436. http://dx.doi.org/10.1093/infdis/172.6.1431.
15. Kaikkonen L, Lankinen H, Harjunpää I, Hokynar K, Söderlund-Venermo M, Oker-Blom C, Hedman L, Hedman K. 1999. Acute-phasespecific heptapeptide epitope for diagnosis of parvovirus B19 infection. J. Clin. Microbiol. 37:3952-3956.
16. Söderlund M, Brown CS, Cohen BJ, Hedman K. 1995. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J. Infect. Dis. 171:710-713. http://dx.doi.org/10.1093/infdis/171.3.710.
17. Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, Niesters HGM, Lawitschka A, Lion T. 2004. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J. Clin. Microbiol. 42:5189-5198. http://dx.doi.org/10.1128/ JCM.42.11.5189-5198.2004. (Pubitemid 39506229)
18. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP. 2007. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 47:1756-1764. http://dx.doi.org/10.1111/j.1537-2995.2007. 01341.x. (Pubitemid 47438539)
19. Brown KE. 2004. Detection and quantitation of parvovirus B19. J. Clin. Virol. 31:1-4. http://dx.doi.org/10.1016/j.jcv.2004.05.001. (Pubitemid 39024376)
20. Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Söderlund-Venermo M, Hedman K. 2006. Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. J. Clin. Virol. 35:400-406. http://dx.doi.org/10.1016/j.jcv.2005. 11.002. (Pubitemid 43324836)
21. Nguyen QT, Wong S, Heegard ED, Brown KE. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374-380. http://dx.doi.org/10.1006/viro.2002.1585. (Pubitemid 35176561)
22. Söderlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P, Allander T, Ruuskanen O, Hedman K. 2009. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg. Infect. Dis. 15:1423-1429. http://dx.doi.org/10.3201/eid1509.090204.
23. Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K. 1999. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 6:725-728. (Pubitemid 29441181)
24. Kaikkonen L, Söderlund-Venermo M, Brunstein J, Schou O, Panum Jensen I, Rousseau S, Caul EO, Cohen B, Valle M, Hedman L, Hedman K. 2001. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J. Med. Virol. 64:360-365. http://dx.doi.org/10.1002/jmv.1059. (Pubitemid 32565134)
25. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamon MS, Kuperman S, del Pozo AE. 2009. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion 49:2352-2358. http://dx.doi.org/10.1111/j.1537-2995.2009.02301.x.
26. Gray JJ, Cohen BJ, Desselberger U. 1993. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J. Virol. Methods 44:11-24. http://dx.doi.org/10.1016/0166- 0934(93)90003-A.
27. Hedman K, Lappalainen M, Söderlund M, Hedman L. 1993. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:123-129. http://dx.doi.org/10.1097/00013542-199307000-00001. (Pubitemid 23225569)
28. Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P. 1999. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J. Clin. Virol. 14:107-118. http://dx.doi.org/10.1016/S1386-6532(99)00051-7. (Pubitemid 29512207)
29. Cohen BJ, Gandhi J, Clewley JP. 2006. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing. J. Clin. Virol. 36:152-155. http://dx.doi.org/10.1016/j.jcv.2006.01.011.
30. Brown KE, Simmonds P. 2007. Parvoviruses and blood transfusion. Transfusion 47:1745-1750. http://dx.doi.org/10.1111/j.1537-2995.2007.01459.x. (Pubitemid 47438565)
31. Beersma MFC, Claas ECJ, Sopaheluakan T, Kroes ACM. 2005. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J. Clin. Virol. 34:71-75. http://dx.doi.org/10.1016/j.jcv.2005.04.005. (Pubitemid 41125879)
32. Norja P, Hokynar K, Aaltonen L-M, Chen R, Ranki A, Leivo T, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger A-M, Schneider B, Fischer H-P, Tolba R, Vapalahti O, Vaheri A, Söderlund-Venermo M, Hedman K. 2006. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl. Acad. Sci. U. S. A. 103:7450-7453. http://dx.doi.org/10.1073/pnas.0602259103. (Pubitemid 43727853)